Online citations, reference lists, and bibliographies.
← Back to Search

Exhaled Biomarkers In Lung Cancer

I. Horváth, Z. Lazar, N. Gyulai, M. Kollai, G. Losonczy
Published 2009 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Lung cancer is the leading cause of cancer death. Results of therapeutic interventions are particularly discouraging when the disease is discovered in an advanced stage. Early diagnosis is limited by the fact that the disease usually develops asymptomatically and available screening methods do not fulfil the requirements for reliable discrimination between patients with lung cancer and subjects not suffering from the disease. Breath sampling is completely noninvasive and provides a potentially useful approach to screening lung cancer. Exhaled biomarkers contain both volatile and nonvolatile molecules. The profile of volatile organic compounds is different in patients with lung cancer than in control subjects. In exhaled breath condensate, the proteomic profile of breath from cancer patients differs from that of healthy smokers. We reviewed the scientific evidence demonstrating that a unique chemical signature can be detected in the breath of patients with lung cancer and that the exhaled breath biomarker profile could aid clinical decision making.
This paper references
10.3233/CBM-2007-3204
Prediction of lung cancer using volatile biomarkers in breath.
M. Phillips (2007)
10.1002/BMC.835
Human exhaled air analytics: biomarkers of diseases.
B. Buszewski (2007)
How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer.
O. Cordero (2008)
10.1002/ijc.11079
Plasma DNA microsatellite panel as sensitive and tumor‐specific marker in lung cancer patients
M. Beau-Faller (2003)
10.1164/RCCM.200411-1523OC
Abnormalities in nitric oxide and its derivatives in lung cancer.
Fares A. Masri (2005)
10.1016/J.LUNGCAN.2006.12.001
Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening.
D. Carter (2007)
10.1056/NEJMOA060476
Survival of patients with stage I lung cancer detected on CT screening.
C. Henschke (2006)
10.1056/NEJMra0802714
Lung cancer.
R. Herbst (2008)
10.1183/09031936.00112306
Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults
B. Balbi (2007)
10.1016/j.lungcan.2008.05.020
Exhaled breath analysis: novel approach for early detection of lung cancer.
Hiang Ping Chan (2009)
10.1007/s11606-007-0411-1
Proteomics as a Method for Early Detection of Cancer: A Review of Proteomics, Exhaled Breath Condensate, and Lung Cancer Screening
D. Conrad (2007)
10.1109/IEMBS.2005.1615826
A Non-invasive Detection of Lung Cancer Combined Virtual Gas Sensors Array with Imaging Recognition Technique
X. Chen (2005)
10.1136/thx.2004.034603
The exhaled biomarker puzzle: bacteria play their card in the exhaled nitric oxide–exhaled breath condensate nitrite game
I. Horváth (2005)
10.1364/OE.16.002387
Cavity-enhanced optical frequency comb spectroscopy: application to human breath analysis.
M. Thorpe (2008)
10.1007/s00011-003-1212-6
Validation of 8-isoprostane and prostaglandin E2 measurements in exhaled breath condensate
P. Montuschi (2003)
10.1021/NL060185T
Toward the nanoscopic "electronic nose": hydrogen vs carbon monoxide discrimination with an array of individual metal oxide nano- and mesowire sensors.
V. Sysoev (2006)
10.1097/JTO.0b013e31814b8be7
Diagnostic Accuracy of MALDI Mass Spectrometric Analysis of Unfractionated Serum in Lung Cancer
Pınar Yıldız (2007)
10.1016/S0956-5663(03)00086-1
Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors.
C. Di Natale (2003)
10.1164/rccm.200807-1068OC
Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study.
G. Sozzi (2009)
10.1016/J.JCLINEPI.2007.04.020
How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design.
D. Ransohoff (2007)
10.1179/135100004225005219
Non-invasive biomarkers of oxidative stress: reproducibility and methodological issues
I. Rahman (2004)
10.1093/JNCI/93.14.1054
Phases of biomarker development for early detection of cancer.
M. Pepe (2001)
10.1016/S0022-5347(05)64924-5
American Cancer Society guidelines for the early detection of cancer.
P. Walsh (2001)
10.1183/09031936.06.00110305
Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate
P. Rosias (2006)
10.1183/09031936.05.00029705
Exhaled breath condensate: methodological recommendations and unresolved questions
I. Horváth (2005)
10.1016/S0895-4356(03)00206-3
Assessment of the accuracy of diagnostic tests: the cross-sectional study.
J. Knottnerus (2003)
10.1183/09031936.00073207
Biomarker reproducibility in exhaled breath condensate collected with different condensers
P. Rosias (2008)
10.1016/J.AMJSURG.2005.06.032
The value of clinical characteristics and breast-imaging studies in predicting a histopathologic diagnosis of cancer or high-risk lesion in patients with spontaneous nipple discharge.
L. J. Adepoju (2005)
10.1002/RCM.984
Quantification of acetaldehyde released by lung cancer cells in vitro using selected ion flow tube mass spectrometry.
D. Smith (2003)
10.1016/J.LUNGCAN.2004.07.995
Fluorescent bronchoscopy: contribution for lung cancer screening?
F. Stanzel (2004)
VEGF , TNFa and 8isoprostane levels in exhaled breath condensate and serum of patients with
E Dalaveris (2008)
10.1007/S00216-007-1163-9
Simultaneous determination of the advanced glycation end product Nɛ-carboxymethyllysine and its precursor, lysine, in exhaled breath condensate using isotope-dilution–hydrophilic-interaction liquid chromatography coupled to tandem mass spectrometry
T. Schettgen (2007)
10.1155/MI/2006/18061
Detection of Erythropoietin in Exhaled Breath Condensate of Nonhypoxic Subjects Using a Multiplex Bead Array
C. Schumann (2006)
10.1073/pnas.161266398
“Electronic nose” detects major histocompatibility complex-dependent prerenal and postrenal odor components
S. Montag (2001)
10.1016/S0009-8981(03)00172-4
Response: scientific basis of the breath methylated alkane contour
M. Phillips (2003)
10.3322/canjclin.39.6.399
Cancer statistics
N. Dubrawsky (1989)
Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of lung cancer patients
M Westhoff (2009)
10.1038/bjc.1998.528
Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer.
C. Liu (1998)
10.1128/MCB.00166-06
5′-AMP-Activated Protein Kinase (AMPK) Is Induced by Low-Oxygen and Glucose Deprivation Conditions Found in Solid-Tumor Microenvironments
K. Laderoute (2006)
10.1183/09031936.02.00062002
Early detection of lung cancer: role of biomarkers
C. Brambilla (2003)
10.1038/nm0808-812
Predicting the future for people with lung cancer
Y. Xie (2008)
10.1016/S0009-8981(03)00173-6
Inadequacy of theoretical basis of breath methylated alkane contour for assessing oxidative stress.
T. Mitsui (2003)
Exhaled breath condensate nitrite--methodological problems of sample collection.
C. Vogelberg (2008)
10.1089/acm.2006.6408
The use of canines in the detection of human cancers.
R. T. Gordon (2008)
Metabonomic analysis of Exhaled Breath Condensate in adults by NMR spectroscopy
Guglielmo de Laurentiis (2008)
10.1073/PNAS.68.10.2374
Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography.
L. Pauling (1971)
10.1002/ijc.21473
Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: A nested case–control study
R. Cirincione (2006)
10.5483/BMBREP.2008.41.9.615
Biomarkers for the lung cancer diagnosis and their advances in proteomics.
Hye-jin Sung (2008)
10.1089/ars.2007.1961
Redox-based therapeutics for lung diseases.
Y. Hoshino (2008)
10.1088/0957-0233/13/3/311
A new method for the simultaneous measurement of aerosol particle size, complex refractive index and particle density
W. W. Szymanski (2002)
10.1002/cyto.a.20231
Multiplex analysis of cytokines in exhaled breath condensate
U. Sack (2006)
10.2174/092986708783769768
Biomarkers in the exhaled breath condensate of healthy adults: mapping the path towards reference values.
A. Koutsokera (2008)
10.1007/s12253-008-9046-8
Differential Cytokine Pattern in the Exhaled Breath of Patients with Lung Cancer
T. Kullmann (2008)
10.1164/RCCM.200409-1184OC
Detection of lung cancer by sensor array analyses of exhaled breath.
R. Machado (2005)
10.1177/1534735405285096
Diagnostic Accuracy of Canine Scent Detection in Early- and Late-Stage Lung and Breast Cancers
Michael McCulloch (2006)
Lung cancer screening using low-dose spiral CT: results of baseline and 1-year followup studies
T Nawa (2002)
10.1055/S-2001-16947
Factors influencing breath condensate volume.
C. Gessner (2001)
10.1016/J.RMED.2005.05.006
Application of laser spectroscopy for measurement of exhaled ethane in patients with lung cancer.
K. Skeldon (2006)
10.1016/J.AMJSURG.2005.11.017
The value of clinical characteristics and breast imaging studies in predicting a histopathologic diagnosis of cancer or high-risk lesion in patients with spontaneous nipple discharge.
R. Bhargav (2007)
10.1006/ABIO.1997.2069
Method for the collection and assay of volatile organic compounds in breath.
M. Phillips (1997)
10.1378/CHEST.122.1.15
Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies.
T. Nawa (2002)
10.1164/AJRCCM.177.2.236
Metabolomics in exhaled breath condensates.
R. Effros (2008)
10.1002/cncr.22844
A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis
X. Chen (2007)
10.1007/S12094-007-0068-6
New screening method for lung cancer by detecting volatile organic compounds in breath
C. Belda-Iniesta (2007)
10.3816/CLC.2008.n.012
Advances in genomic and proteomic studies of non-small-cell lung cancer: clinical and translational research perspective.
R. Dziadziuszko (2008)
10.1183/09031936.02.00053402
Effect of oxygen on breath markers of oxidative stress
M. Phillips (2003)
10.3310/HTA10030
The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews.
C. Black (2006)
10.1183/09031936.00081707
Validation of assays for inflammatory mediators in exhaled breath condensate
D. Bayley (2008)
10.1016/S0378-4347(99)00127-9
Variation in volatile organic compounds in the breath of normal humans.
M. Phillips (1999)
VEGF, TNF-a and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer
E Dalaveris (2008)
Lung cancer diagnosis by the analysis of exhaled breath with a colorimetric sensor array
PJ Mazzone (2007)
10.1136/bmj.330.7493.724
Evidence based diagnostics
C. Gluud (2005)
10.1007/s00330-003-2200-5
Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers
S. Diederich (2003)
10.1136/jech.56.5.323
The winding road towards evidence based diagnoses
I. Hernández-Aguado (2002)
10.1001/ARCHINTE.167.21.2289
Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study.
H. Welch (2007)
10.2174/138620708783877726
High throughput screening informatics.
X. Ling (2008)
10.1378/CHEST.111.6.1710
Revisions in the International System for Staging Lung Cancer.
C. Mountain (1997)
10.1016/j.otohns.2007.02.005
In Vitro Discrimination of Tumor Cell Lines with an Electronic Nose
Kristin B Gendron (2007)
10.1513/PATS.200406-710ST
ATS workshop proceedings: exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate.
P. Silkoff (2006)
10.1016/j.rmed.2007.12.013
Influence of condensing equipment and temperature on exhaled breath condensate pH, total protein and leukotriene concentrations.
K. Czebe (2008)
10.1016/J.JCHROMB.2007.10.031
Simultaneous determination of 3-nitrotyrosine, tyrosine, hydroxyproline and proline in exhaled breath condensate by hydrophilic interaction liquid chromatography/electrospray ionization tandem mass spectrometry.
A. Conventz (2007)
10.1378/CHEST.123.1_SUPPL.83S
Screening for lung cancer: the guidelines.
P. Bach (2003)
10.1021/nl801577u
Detecting simulated patterns of lung cancer biomarkers by random network of single-walled carbon nanotubes coated with nonpolymeric organic materials.
G. Peng (2008)
10.1177/1534735408319058
Human Ovarian Carcinomas Detected by Specific Odor
G. Horvath (2008)
Correlation of 8isoprostane, interleukin-6 and cardiac functions with clinical score in childhood obstructive sleep apnoea
MA Biltagi (2008)
10.1164/rccm.200809-1395ED
Biomarkers for lung cancer screening: interpretation and implications of an early negative advanced validation study.
E. Hirschowitz (2009)
10.1164/AJRCCM/148.3.778
Detection of nonvolatile macromolecules in breath. A possible diagnostic tool?
L. Scheideler (1993)
10.1164/AJRCCM.165.1.2104131
Expression and activity of pH-regulatory glutaminase in the human airway epithelium.
J. Hunt (2002)
10.1007/s00011-008-8009-6
Adenosine triphosphate in exhaled breath condensate of healthy subjects and patients with chronic obstructive pulmonary disease
Z. Lázár (2008)
10.1016/J.RMED.2007.09.005
Non-invasive evaluation of pulmonary glutathione in the exhaled breath condensate of otherwise healthy alcoholics.
M. Yeh (2008)
10.1164/RCCM.200503-439OC
3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer.
G. E. Carpagnano (2005)
10.1517/14622416.5.6.709
Research issues and strategies for genomic and proteomic biomarker discovery and validation: a statistical perspective.
Z. Feng (2004)
10.1007/s00011-005-1361-x
Comparative measurement of thromboxane A2 metabolites in exhaled breath condensate by different immunoassays
É. Huszár (2005)
10.1378/chest.124.2.614
The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening.
J. Wisnivesky (2003)
10.1016/j.chroma.2008.10.125
Organic metabolites in exhaled human breath--a multivariate approach for identification of biomarkers in lung disorders.
E. M. Gaspar (2009)
10.1164/AJRCCM.177.2.236B
Particulate air pollution in Irish pubs is grossly underestimated.
M. Travers (2008)
10.1183/09031936.01.00231201
"Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases", summary of the ERS Research Seminar in Budapest, Hungary, September, 1999.
I. Horváth (2001)
10.3322/CA.2007.0010
Cancer Statistics, 2008
A. Jemal (2008)
10.1007/BF02535990
Effect of regulating cholesterol biosynthesis on breath isoprene excretion in men
B. Stone (2006)
10.1016/j.jprot.2008.03.002
Proteomic analysis of exhaled breath condensate from single patients with pulmonary emphysema associated to alpha1-antitrypsin deficiency.
M. Fumagalli (2008)
10.5301/JBM.2008.172
Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer.
G. E. Carpagnano (2002)
10.1378/CHEST.117.4.999
Oxidative stress after lung resection therapy: A pilot study.
E. C. Lases (2000)
10.1016/S0925-4005(00)00617-1
Transportability of data between electronic noses: mathematical methods
M. Balaban (2000)
Expression and activity of pHregulatory glutaminase in the human airway epithelium
JF Hunt (2002)
10.1177/205873920601900107
c-MYC deregulation is involved in melphalan resistance of multiple myeloma: role of PDGF-BB.
C. Greco (2006)
10.1080/10715760310001623331
ReviewBiomarkers in Breath Condensate: A promising New Non-invasive Technique in Free Radical Research
I. Rahman (2003)
10.1136/thx.2004.030635
Origin of nitrite and nitrate in nasal and exhaled breath condensate and relation to nitric oxide formation
H. Marteus (2005)
10.1007/S00420-007-0242-8
Chromium in exhaled breath condensate and pulmonary tissue of non-small cell lung cancer patients
M. Goldoni (2008)
10.1186/1476-4598-7-81
DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update
Paul P. Anglim (2008)
10.1097/JTO.0b013e3181914506
Detection and Localization of Intraepithelial Neoplasia and Invasive Carcinoma Using Fluorescence-Reflectance Bronchoscopy: An International, Multicenter Clinical Trial
E. Edell (2009)
10.1183/09031936.06.00101705
Time course of exhaled hydrogen peroxide and nitric oxide during chemotherapy
A. Wewel (2006)
10.1088/1752-7155/2/2/026007
Impact of sampling procedures on the results of breath analysis.
W. Miekisch (2008)
non-smallcell lung cancer
M Goldoni (2004)
10.1016/j.lungcan.2008.08.015
VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer.
E. Dalaveris (2009)
10.1378/CHEST.07-1349
Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
P. Bach (2007)
10.1016/j.canlet.2008.01.037
Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells.
Sun-Jack Kim (2008)
10.1093/JJCO/HYE028
Influence of thoracic radiotherapy on exhaled nitric oxide levels in patients with lung cancer.
M. Koizumi (2001)
10.1159/000077992
Endothelin-1 Is Increased in the Breath Condensate of Patients with Non-Small-Cell Lung Cancer
G.E. Carpagnano (2004)
10.1021/ac801645t
Data-driven optimization of metabolomics methods using rat liver samples.
Gauri Parab (2009)
10.1164/RCCM.200207-716BC
Comparison of nasal and oral inhalation during exhaled breath condensate collection.
G. Vass (2003)
10.1097/MCP.0b013e32818b27d3
Lung cancer screening: has there been any progress? Computed tomography and autofluorescence bronchoscopy
P. Lee (2007)
10.1371/journal.pmed.0030442
Projections of Global Mortality and Burden of Disease from 2002 to 2030
C. Mathers (2006)
Lung cancer screening with low-dose computed tomography: Canadian experience.
H. Roberts (2007)
10.1183/09031936.00072408
Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy
G. de Laurentiis (2008)
10.3322/canjclin.53.1.27
American Cancer Society Guidelines for the Early Detection of Cancer, 2003
R. Smith (2003)
10.1378/CHEST.122.4.1162
Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients.
G. E. Carpagnano (2002)
10.1016/S0140-6736(99)06093-6
Early Lung Cancer Action Project: overall design and findings from baseline screening
C. Henschke (1999)
10.1183/09031936.00084006
Exhaled breath condensate pH standardised for CO2 partial pressure
T. Kullmann (2007)
10.1158/1055-9965.EPI-07-2619
Biomarkers for Cancer Risk, Early Detection, and Prognosis: The Validation Conundrum
D. Brenner (2007)
tissue of patients with lung cancer
EC Lases (2008)
Opinion: understanding ‘‘global’’ systems biology: metabonomics and continuum of metabolism
JK Nicholson (2003)
Toward the nanoscopic electronic nose: hydrogen versus carbon monoxide discrimination with an array of individual metal oxide nano- and mesowire
VV Sysoev (2006)
10.1016/J.MEHY.2005.08.027
Is olfactory detection of human cancer by dogs based on major histocompatibility complex-dependent odour components?--A possible cure and a precocious diagnosis of cancer.
S. Balseiro (2006)
10.1016/J.LUNGCAN.2003.08.034
Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients.
C. Gessner (2004)
10.1089/HAM.2005.6.289
L-arginine supplementation enhances exhaled NO, breath condensate VEGF, and headache at 4,342 m.
J. K. Mansoor (2005)
10.1158/1940-6207.CAPR-08-0060
An Expanded Risk Prediction Model for Lung Cancer
M. Spitz (2008)
Detection of p53 mutations in exhaled breath condensate of non small cell lung cancer patients
C Gessner (2004)
10.1016/J.RMED.2007.10.002
Within- and between-person variability of exhaled breath condensate pH and NH4+ in never and current smokers.
R. Do (2008)
10.1016/J.JINORGBIO.2007.10.001
Hydrogen-deuterium exchange mass spectrometry for investigation of backbone dynamics of oxidized and reduced cytochrome P450cam.
Y. Hamuro (2008)
10.1054/bjoc.2000.1531
Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner
S. Sone (2001)
10.1183/09031936.00089807
Extracellular purines are biomarkers of neutrophilic airway inflammation
C. R. Esther (2008)
10.1159/000085106
Analysis of Growth Factors and Inflammatory Cytokines in Exhaled Breath Condensate from Asthmatic Children
T. Leung (2005)
10.1093/CLINCHEM/31.8.1278
Volatile organic compounds in exhaled air from patients with lung cancer.
S. Gordon (1985)
[Detection of mutations of the K-ras gene in condensed breath of patients with non-small-cell lung carcinoma (NSCLC) as a possible noninvasive screening method].
C. Gessner (1998)
TNF-a and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer
E Dalaveris (2008)
10.1634/theoncologist.2008-0027
Commentary: CT screening for lung cancer--caveat emptor.
J. Jett (2008)
10.1016/J.JACI.2007.05.043
An electronic nose in the discrimination of patients with asthma and controls.
S. Dragonieri (2007)
10.1378/CHEST.123.6.2115
Detection of lung cancer with volatile markers in the breath.
M. Phillips (2003)
10.1191/1740774506cn130oa
Evaluating markers for the early detection of cancer: overview of study designs and methods
S. Baker (2006)
10.1186/1465-9921-6-71
Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study
D. Poli (2005)
10.1016/J.JACI.2004.08.042
The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma.
P. Silkoff (2004)
Validation of 8isoprostane and prostaglandin E2 measurements in exhaled breath condensate
P Montuschi (2003)
10.1183/2312508x.erm6815
Lung cancer.
H. Hansen (1990)
10.2174/092986708783955392
Adenosine and adenosine receptors in the pathomechanism and treatment of respiratory diseases.
G. Vass (2008)
10.1016/S0378-4347(00)80627-1
Analysis of lung air from patients with bronchogenic carcinoma and controls using gas chromatography-mass spectrometry.
G. Preti (1988)
10.1016/S0140-6736(98)07552-7
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study
M. Phillips (1999)
10.1007/978-1-60327-517-0_31
Pooling data when analyzing biomarkers subject to a limit of detection.
L. Rosenthal (2008)
10.1183/09031936.02.00005002
Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma
E. Huszár (2002)
10.1080/02770900701752573
Nε-(Carboxymethyl)Lysine, a Major Advanced Glycation End Product in Exhaled Breath Condensate as a Biomarker of Small Airway Involvement in Asthma
Y. Tochino (2007)
10.1164/RCCM.200210-1253OC
Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease.
M. Corradi (2003)
10.1007/BF03032399
Genomics of lung cancer may change diagnosis, prognosis and therapy
L. Kopper (2009)
10.1164/ajrccm.165.5.2101018
Dilution of respiratory solutes in exhaled condensates.
R. Effros (2002)
10.1002/rcm.3408
A mass spectrometric method to simultaneously measure a biomarker and dilution marker in exhaled breath condensate.
C. Esther (2008)
10.1378/chest.107.6_supplement.280s
Molecular markers in early cancer detection. New screening tools.
J. Mulshine (1995)
Heme oxygenase-1 induction and exhaled markers of oxidative stress in lung diseases
I. Horváth (2001)
10.1016/j.ejca.2008.11.043
Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis.
P. Gu (2009)
10.1016/J.CCCN.2004.04.023
Diagnostic potential of breath analysis--focus on volatile organic compounds.
W. Miekisch (2004)
10.1164/RCCM.200606-769OC
Metabolomics applied to exhaled breath condensate in childhood asthma.
S. Carraro (2007)
10.1186/1471-2105-8-239
Probabilistic prediction and ranking of human protein-protein interactions
M. Scott (2007)
10.1136/thx.2008.099465
Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study
M. Westhoff (2009)
10.1136/thx.2006.072892
Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array
P. Mazzone (2007)
10.1016/j.lungcan.2008.08.008
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
S. Dragonieri (2009)
10.1200/JCO.2007.13.5392
Panel of serum biomarkers for the diagnosis of lung cancer.
E. Patz (2007)
10.1186/1471-2407-5-83
Application of serum SELDI proteomic patterns in diagnosis of lung cancer
Shuan-ying Yang (2005)
10.1093/CLINCHEM/34.8.1613
A computerized classification technique for screening for the presence of breath biomarkers in lung cancer.
H. O'neill (1988)
10.1196/annals.1384.011
Human Breath Odors and Their Use in Diagnosis
C. L. Whittle (2007)
10.1088/1752-7155/2/4/046003
Quantification of trace levels of the potential cancer biomarkers formaldehyde, acetaldehyde and propanol in breath by SIFT-MS.
P. Španěl (2008)
10.1164/RCCM.200707-1136OC
3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.
G. E. Carpagnano (2008)
Screening for lung cancer: ACCP evidence-based clinical practice guidelines
P B Bach (2007)
10.1039/B603189G
Quantitative assessment of olfactory receptors activity in immobilized nanosomes: a novel concept for bioelectronic nose.
J. Vidic (2006)
10.1007/BF02535255
Determination of ethane and pentane in free oxygen radical-induced lipid peroxidation
O. Pitkänen (2006)
10.1016/S1556-0864(15)30352-X
Profiling Tumor-Associated Antibodies for Early Detection of Non-small Cell Lung Cancer
Li Zhong (2006)
10.1016/S0140-6736(89)92257-5
SNIFFER DOGS IN THE MELANOMA CLINIC?
H. Williams (1989)
10.1093/jnci/djn326
Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design
M. Pepe (2008)
10.1016/S0140-6736(03)14188-8
Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results
U. Pastorino (2003)
10.1164/rccm.200807-1153OC
Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project.
C. Verri (2009)
10.1007/S00604-006-0623-9
Data analysis for electronic nose systems
S. Scott (2006)
Increased 8isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients
GE Carpagnano (2002)
10.7326/0003-4819-138-1-200301070-00012-w1
The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration
P. Bossuyt (2003)
10.1111/j.1651-2227.2008.00927.x
Correlation of 8‐isoprostane, interleukin‐6 and cardiac functions with clinical score in childhood obstructive sleep apnoea
M. A. Biltagi (2008)
10.1007/s00408-008-9086-6
Drinking Influences Exhaled Breath Condensate Acidity
T. Kullmann (2008)
10.1136/bmj.324.7335.477
Evaluation of diagnostic procedures
J. Knottnerus (2002)
10.2147/COPD.2007.2.1.2
Reproducibility of exhaled biomarkers in COPD—the road less traveled
I. Horváth (2007)
10.1183/09031936.00080207
Collection devices influence the constituents of exhaled breath condensate
J. Liu (2007)
10.1136/thx.53.8.668
Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress
I. Horváth (1998)
10.1016/J.HEALUN.2003.07.017
Heart allograft rejection: detection with breath alkanes in low levels (the HARDBALL study).
M. Phillips (2004)
Induced sputum, exhaled breath condensate and nasal lavage fluid in electroplating workers exposed to chromium.
N. Murgia (2006)
10.1002/cncr.23059
Computed tomography screening for lung cancer: Review of screening principles and update on current status
W. Black (2007)
10.1097/JTO.0b013e31817c7439
Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer.
P. Mazzone (2008)
10.1016/j.cca.2008.02.021
Detection of lung cancer using weighted digital analysis of breath biomarkers.
M. Phillips (2008)
10.1097/JTO.0B013E318158EED4
The impact of genetic markers on the diagnosis of lung cancer: a current perspective.
J. Chorostowska-Wynimko (2007)
10.1038/NCHEMBIO882
Chemical sensing of DNT by engineered olfactory yeast strain.
V. Radhika (2007)
10.3727/000000006783980900
IL-2, TNF-α, and leptin : Local versus systemic concentrations in NSCLC patients
G. E. Carpagnano (2006)
10.1016/J.IJMS.2007.05.012
Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas
A. Wehinger (2007)



This paper is referenced by
10.20944/preprints201810.0390.v1
A Review of the Usefulness of Non-invasive Exhaled Breath Condensate pH Analysis for Diseases Diagnosis with Elements of Meta-analysis: An Update from 2012
Marcin Muża (2018)
Real-time breath gas analysis of carbon monoxide : laser-based detection and pulmonary gas exchange modeling
R. Ghorbani (2018)
10.3109/21691401.2014.975237
Drug delivery and nanodetection in lung cancer
F. Badrzadeh (2016)
10.1016/j.critrevonc.2020.103037
Volatile organic compounds in human matrices as lung cancer biomarkers: A systematic review.
Eline Janssens (2020)
10.1016/j.ijporl.2013.04.025
Exhaled biomarker pattern is altered in children with obstructive sleep apnoea syndrome.
P. Benedek (2013)
Antioxidants, Cytokines and Markers of Oxidative Stress in Lung Cancer
Marika Crohns (2010)
10.1088/1752-7163/aa8b25
Two techniques to sample non-volatiles in breath-exemplified by methadone.
Göran Ljungkvist (2017)
10.1586/14737159.2015.1043895
Exhaled breath analysis by electronic nose in respiratory diseases
S. Scarlata (2015)
10.3390/jcm8020235
Sensors for Lung Cancer Diagnosis
R. Capuano (2019)
10.1039/c1an15618g
A novel microreactor approach for analysis of ketones and aldehydes in breath.
Xiao-An Fu (2011)
10.1159/000488007
Non-Invasive Detection of Anastomotic Leakage Following Esophageal and Pancreatic Surgery by Urinary Analysis
V. Plat (2018)
PROGNOSIS OF BRONCHOGENIC CARCINOMA USING MACHINE LEARNING WITH A RESTORATIVE REMEDY
Dr. Shubhangi (2019)
10.3793/JAAM.7.66
Disease and Smell: "Byoshu"
M. Kusuhara (2010)
10.4155/bio.13.183
Detection of volatile organic compounds as biomarkers in breath analysis by different analytical techniques.
B. Buszewski (2013)
10.1183/09031936.00078812
Application of ’omics technologies to biomarker discovery in inflammatory lung diseases
C. Wheelock (2013)
10.1088/1752-7155/10/3/034001
Exhaled breath condensate for lung cancer protein analysis: a review of methods and biomarkers.
S. A. Hayes (2016)
10.3390/s101009127
Electronic Nose Breathprints Are Independent of Acute Changes in Airway Caliber in Asthma
Z. Lazar (2010)
10.1183/09031936.00051711
Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon
R. Ehmann (2011)
10.1016/J.JAEROSCI.2013.06.003
Diagnosing obstructive respiratory diseases using exhaled aerosol fingerprints: A feasibility study
Jinxiang Xi (2013)
10.1007/S12127-011-0078-5
Significant different volatile biomarker during bronchoscopic ion mobility spectrometry investigation of patients suffering lung carcinoma
J. Baumbach (2011)
10.1515/cclm-2012-0593
Exhaled breath condensate: a comprehensive update
H. Ahmadzai (2013)
10.1016/j.cca.2010.06.005
Breath biomarkers for lung cancer detection and assessment of smoking related effects--confounding variables, influence of normalization and statistical algorithms.
S. Kischkel (2010)
Canine Scent Detection of Volatile Elements, Characteristic of Malignant Cells, in Cell Cultures.
Uri Yoel (2015)
10.5772/INTECHOPEN.72398
Volatile Organic Compound and Metabolite Signatures as Pathogen Identifiers and Biomarkers of Infectious Disease
E. Hong-Geller (2017)
10.1002/cam4.162
Noninvasive detection of lung cancer using exhaled breath
Xiao-An Fu (2014)
10.1088/1752-7155/6/3/036007
Data interpretation in breath biomarker research: pitfalls and directions.
W. Miekisch (2012)
10.3390/s141018982
Chemoresistive Gas Sensors for the Detection of Colorectal Cancer Biomarkers
C. Malagù (2014)
10.7150/thno.11107
CFD Modeling and Image Analysis of Exhaled Aerosols due to a Growing Bronchial Tumor: towards Non-Invasive Diagnosis and Treatment of Respiratory Obstructive Diseases
Jinxiang Xi (2015)
10.1016/j.jtho.2018.02.026
Breathprinting and Early Diagnosis of Lung Cancer
G. Rocco (2018)
10.4187/respcare.05618
Low-Flow Domiciliary Oxygen as a Mechanism of Ongoing Oxidative Stress
Jill M. Stulce (2019)
10.25772/VPA8-M098
Low-Flow Domiciliary Oxygen as a Mechanism of Ongoing Oxidative Stress in COPD Patients
Jill M. Stulce (2015)
olatile Organic Compounds in Exhaled Breath in a Healthy Population: ffect of Tobacco Smoking
Javier Jareño-Esteban (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar